News & Alerts
-
Mar- 2024 -28 March
U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia
On March 27, the U.S. Food and Drug Administration (FDA) granted approval to Akebia Therapeutics’ (AKBA.O) drug, vadadustat, for the…
Read More » -
28 March
US FDA Approves Merck’s Winrevair for Rare Lung Condition
The U.S. Food and Drug Administration’s recent approval of Merck’s (MRK.N) treatment for adults suffering from high blood pressure due…
Read More » -
27 March
Alternative Medicine Modalities for Primary Health Care: A Primer
In recent years, there has been growing interest in alternative medicine modalities as complementary options to conventional primary health care.…
Read More » -
25 March
US Impose Fentanyl-related Sanctions on Sinaloa Members, Mexico-based Entities
The United States’ decision to impose sanctions on 15 Sinaloa Cartel members and six Mexico-based entities marks a significant escalation…
Read More » -
22 March
How Safety Innovations are Transforming Healthcare
In the quickly evolving landscape of healthcare, safety innovations stand at the very front of transforming patient care and functional…
Read More » -
21 March
Testosterone Replacement Therapy Market to Reach $2.9 Billion Globally, By 2032
The Testosterone Replacement Therapy (TRT) market is poised for significant growth, with a projected global value of $2.9 billion by…
Read More » -
21 March
Global Menopause Market Analysis Report 2024
The Global Menopause Market is projected to witness substantial growth, with an expected market size of USD 24.4 billion by…
Read More » -
20 March
Global Parenteral Nutrition Market Expected to Reach $11.47 Billion by 2030
Research and Markets, a leading market research firm, has recently released a comprehensive report titled “Parenteral Nutrition Market: Global Industry…
Read More » -
18 March
The US FDA Rejects Viatris’s Injection for Multiple Sclerosis
The U.S. Food and Drug Administration (FDA) has declined to approve Viatris and Mapi Pharma’s once-a-month injection intended for treating…
Read More » -
18 March
Madrigal Pharma Shares Surges After Drug Wins First Approval For Fatty Liver Disease NASH
Madrigal Pharmaceuticals (MDGL.O) experienced a significant surge in its stock value, jumping by as much as 23% on Friday, following…
Read More »